Aik-choon Tan
Affiliations: | Medicine | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Google:
"Aik-choon Tan"Collaborators
Sign in to add collaborator| Lynn E. Heasley | collaborator | 2009-2019 | University of Colorado, Denver |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chaudhary R, Slebos RJC, Noel LC, et al. (2023) EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma. Cancer Research Communications. 3: 896-907 |
| Alem D, Yang X, Beato F, et al. (2023) Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancer. Molecular Carcinogenesis |
| Rose MM, Espinoza VL, Hoff KJ, et al. (2023) BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer. Cancers. 15 |
| Napoli M, Wu SJ, Gore BL, et al. (2022) ΔNp63 regulates a common landscape of enhancer associated genes in non-small cell lung cancer. Nature Communications. 13: 614 |
| Chai AWY, Tan AC, Cheong SC. (2021) Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis. Scientific Reports. 11: 23933 |
| Nassar KW, Hintzsche JD, Bagby SM, et al. (2021) Targeting CDK4/6 represents a therapeutic vulnerability in acquired BRAF/MEK inhibitor resistant melanoma. Molecular Cancer Therapeutics |
| Gurule NJ, McCoach CE, Hinz TK, et al. (2021) A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. Npj Precision Oncology. 5: 41 |
| Schubert L, Le AT, Estrada-Bernal A, et al. (2021) . Molecular Pharmacology |
| Chaudhary R, Slebos RJC, Song F, et al. (2020) Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma. Molecular Carcinogenesis |
| He T, Wildey G, McColl K, et al. (2020) Identification of RUNX1T1 as a potential epigenetic modifier in small cell lung cancer. Molecular Oncology |